HomeCompareBMXMF vs PLD

BMXMF vs PLD: Dividend Comparison 2026

BMXMF yields 1.00% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $1.29M in total portfolio value
10 years
BMXMF
BMXMF
● Live price
1.00%
Share price
$102.25
Annual div
$1.03
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.62M
Annual income
$3,874,899.32
Full BMXMF calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — BMXMF vs PLD

📍 PLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBMXMFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BMXMF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BMXMF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BMXMF
Annual income on $10K today (after 15% tax)
$85.29/yr
After 10yr DRIP, annual income (after tax)
$3,293,664.42/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, PLD beats the other by $744,451.99/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BMXMF + PLD for your $10,000?

BMXMF: 50%PLD: 50%
100% PLD50/50100% BMXMF
Portfolio after 10yr
$5.26M
Annual income
$4,312,812.25/yr
Blended yield
81.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

BMXMF
Analyst Ratings
4
Buy
1
Hold
Consensus: Buy
Altman Z
6.7
Piotroski
7/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BMXMF buys
0
PLD buys
0
No recent congressional trades found for BMXMF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBMXMFPLD
Forward yield1.00%3.10%
Annual dividend / share$1.03$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%74.4%
Portfolio after 10y$4.62M$5.91M
Annual income after 10y$3,874,899.32$4,750,725.19
Total dividends collected$4.53M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: BMXMF vs PLD ($10,000, DRIP)

YearBMXMF PortfolioBMXMF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$10,901$200.68$11,241$540.96$340.00PLD
2$12,073$408.90$13,019$991.13$946.00PLD
3$13,764$846.46$15,801$1,870.97$2.0KPLD
4$16,532$1,803.86$20,609$3,701.21$4.1KPLD
5$21,738$4,049.60$29,919$7,867.97$8.2KPLD
6$33,213$9,953.40$50,631$18,617.74$17.4KPLD
7$63,964$28,425.29$105,528$51,352.20$41.6KPLD
8$170,764$102,322.42$287,364$174,449.42$116.6KPLD
9$693,315$510,597.75$1,081,760$774,280.77$388.4KPLD
10$4,616,746$3,874,899.32$5,908,209$4,750,725.19$1.29MPLD

BMXMF vs PLD: Complete Analysis 2026

BMXMFStock

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

Full BMXMF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this BMXMF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BMXMF vs SCHDBMXMF vs JEPIBMXMF vs OBMXMF vs KOBMXMF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.